The role of transcription factors in allergic inflammation

被引:29
作者
Escoubet-Lozach, L
Glass, CK
Wasserman, SI
机构
[1] Univ Calif San Diego, Dept Med, Div Cellular & Mol Med, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Div Rheumatol Allergy & Immunol, Dept Med, La Jolla, CA 92093 USA
关键词
gene transcription; transcription factors; nuclear receptors; allergic inflammation; coactivators; compressors;
D O I
10.1067/mai.2002.128076
中图分类号
R392 [医学免疫学];
学科分类号
100102 [免疫学];
摘要
The induction of allergic inflammation and the expression of allergic disorders are dependent on the coordinated regulation of numerous genes. The products of these genes determine lymphocyte phenotype, immunologic responsiveness, eosinophil and mast cell development, activation, migration and life span, adhesion molecule expression, cytokine synthesis, cell-surface receptor display, and processes governing fibrosis and tissue repair. Although the expression of gene products involved in these processes is regulated at multiple levels (eg, transcription, mRNA processing, translation, phosphorylation, and degradation), transcription represents an essential and often the most important determinant of their contribution to cellular function. Signal-dependent and cell type-specific regulation of gene expression is generally achieved by means of combinatorial interactions between sequence-specific transcription factors that recruit chromatin remodeling machinery and general transcription factors to promoter and enhancer regions of RNA polymerase II-dependent genes. As targets of signal-transduction pathways, transcription factors integrate the response of the cell to the myriad of inputs it receives. This integration can be accomplished by the effect of signaling cascades on the activation status or subcellular locus of transcription factors or by transcription factor dimerization induced by means of ligand binding. This review will identify the major families of transcription factors important in allergic mechanisms and discuss their interactions, their mechanisms of action, and their interrelated and competitive actions, as well as implications for therapy of allergic disorders.
引用
收藏
页码:553 / 564
页数:12
相关论文
共 158 条
[1]
Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice [J].
Akimoto, T ;
Numata, F ;
Tamura, M ;
Takata, Y ;
Higashida, N ;
Takashi, T ;
Takeda, K ;
Akira, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (09) :1537-1542
[2]
THE ROLE OF JUN, FOS AND THE AP-1 COMPLEX IN CELL-PROLIFERATION AND TRANSFORMATION [J].
ANGEL, P ;
KARIN, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1072 (2-3) :129-157
[3]
Azuma M, 2000, ARTHRITIS RHEUM, V43, P1756, DOI 10.1002/1529-0131(200008)43:8<1756::AID-ANR12>3.0.CO
[4]
2-H
[5]
STEROID-HORMONE RECEPTORS - MANY ACTORS IN SEARCH OF A PLOT [J].
BEATO, M ;
HERRLICH, P ;
SCHUTZ, G .
CELL, 1995, 83 (06) :851-857
[6]
Regulation of peroxisome proliferator-activated receptor γ expression in human asthmatic airways -: Relationship with proliferation, apoptosis, and airway remodeling [J].
Benayoun, L ;
Letuve, S ;
Druilhe, A ;
Boczkowski, J ;
Dombret, MC ;
Mechighel, P ;
Megret, J ;
Leseche, G ;
Aubier, M ;
Pretolani, M .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (08) :1487-1494
[7]
Histone modifications in transcriptional regulation [J].
Berger, SL .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2002, 12 (02) :142-148
[8]
Regulation of the human interleukin-5 promoter by Ets transcription factors -: Ets1 and Ets2, but not Elf-1, cooperate with GATA3 and HTLV-I Tax1 [J].
Blumenthal, SG ;
Aichele, G ;
Wirth, T ;
Czernilofsky, AP ;
Nordheim, A ;
Dittmer, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (18) :12910-12916
[9]
Mechanisms of persistent NF-κB activity in the bronchi of an animal model of asthma [J].
Bureau, F ;
Delhalle, S ;
Bonizzi, G ;
Fiévez, L ;
Dogné, S ;
Kirschvink, N ;
Vanderplasschen, A ;
Merville, MP ;
Bours, V ;
Lekeux, P .
JOURNAL OF IMMUNOLOGY, 2000, 165 (10) :5822-5830
[10]
Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway [J].
Caelles, C ;
González-Sancho, JM ;
Muñoz, A .
GENES & DEVELOPMENT, 1997, 11 (24) :3351-3364